These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial. Byington RP; Curb JD; Mattson ME JAMA; 1985 Mar 22-29; 253(12):1733-6. PubMed ID: 3974051 [TBL] [Abstract][Full Text] [Related]
3. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial. Goldstein S Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840 [TBL] [Abstract][Full Text] [Related]
4. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157 [TBL] [Abstract][Full Text] [Related]
5. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group. Byington RP Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483 [TBL] [Abstract][Full Text] [Related]
11. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771 [TBL] [Abstract][Full Text] [Related]
12. The relationship of treatment adherence to the risk of death after myocardial infarction in women. Gallagher EJ; Viscoli CM; Horwitz RI JAMA; 1993 Aug; 270(6):742-4. PubMed ID: 8336377 [TBL] [Abstract][Full Text] [Related]
13. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression. Shivkumar K; Schultz L; Goldstein S; Gheorghiade M Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974 [TBL] [Abstract][Full Text] [Related]
14. Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience. Lichstein E; Morganroth J; Harrist R; Hubble E Circulation; 1983 Jun; 67(6 Pt 2):I5-10. PubMed ID: 6342839 [TBL] [Abstract][Full Text] [Related]
15. The Beta-blocker Heart Attack Trial. Furberg CD Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615 [TBL] [Abstract][Full Text] [Related]
16. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias. Morganroth J; Lichstein E; Byington R Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736 [TBL] [Abstract][Full Text] [Related]
17. Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness. Viscoli CM; Horwitz RI; Singer BH Ann Intern Med; 1993 Jan; 118(2):99-105. PubMed ID: 8416325 [TBL] [Abstract][Full Text] [Related]
18. Effects of propranolol on blood lipids and lipoproteins in myocardial infarction. Shulman RS; Herbert PN; Capone RJ; McClure D; Hawkins CM; Henderson LO; Saritelli A; Campbell J Circulation; 1983 Jun; 67(6 Pt 2):I19-21. PubMed ID: 6851036 [TBL] [Abstract][Full Text] [Related]
19. The Beta Blocker Heart Attack Trial: recruitment experience. Goldstein S; Byington R Control Clin Trials; 1987 Dec; 8(4 Suppl):79S-85S. PubMed ID: 2894282 [TBL] [Abstract][Full Text] [Related]
20. Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial. Haywood LJ Am Heart J; 1984 Sep; 108(3 Pt 2):787-93. PubMed ID: 6148005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]